The pleomorphic pathology of inherited parkinson’s disease: Lessons from LRRK2 Vincenzo Bonifati Invited Commentary Pages: 355 - 357
Donepezil in patients with severe alzheimer’s disease Karen Marder Clinical Trials Report Pages: 363 - 364
Current treatment of mild cognitive impairment and alzheimer’s disease David S. Knopman OriginalPaper Pages: 365 - 371
New pathways in drug discovery for alzheimer’s disease Eric R. SiemersRobert A. DeanPatrick C. May OriginalPaper Pages: 372 - 378
Olfactory dysfunction as a predictor of neurodegenerative disease Mark W. AlbersMatthias H. TabertD. P. Devanand OriginalPaper Pages: 379 - 386
The relationship between amyotrophic lateral sclerosis and frontotemporal dementia George M. RingholzScott R. Greene OriginalPaper Pages: 387 - 392
Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases M. Tariq Bhatti OriginalPaper Pages: 403 - 413
Localizing forms of nystagmus: Symptoms, diagnosis, and treatment Andrew G. LeePaul W. Brazis OriginalPaper Pages: 414 - 420
Intravenous immunoglobulin treatment in acute optic neuritis James Corbett Clinical Trials Report Pages: 421 - 421
Mechanisms and models of α-synuclein-related neurodegeneration Wolfdieter SpringerPhilipp J. Kahle OriginalPaper Pages: 432 - 436
Genetic defects of human brain development Jenny CarmichaelChristopher Geoffrey Woods OriginalPaper Pages: 437 - 446